Nuclera, a UK-based biotech company developing cutting-edge benchtop protein printing technologies, announces the opening of its US subsidiary in Boston, MA. The addition of this US facility in
E Ink Holdings Inc : Nuclera erwirbt E Ink-Geschäftsbereich für digitale Mikrofluidik finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Nuclera fait l acquisition de l unité de microfluidique numérique d E Ink itespresso.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itespresso.fr Daily Mail and Mail on Sunday newspapers.
Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ink technology, are pleased to announce the acquisition
Last month, an antitrust law overhaul was proposed: the Competition and Antitrust Law Enforcement Reform Act. CLERA constitutes the most significant change to antitrust law in ahwhile. In particular, it poses substantial new antitrust concerns for tech companies seeking to engage in standard M&As.